LexDanaLexDanabeta
Inventor

Lin Zhi

Inventor
San Diego, CA, US

Overview

111→
Patents
1997–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 111 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds4%
Y02ATechnologies for adaptation to climate change4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
A61NElectrotherapy2%
C07HSugars1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,874,638Methods and compositions for modulating hormone levels202010,807,983Imidazo-fused heterocycles and uses thereof202010,736,875Methods and compositions associated with the granulocyte colony-stimulating factor receptor202010,730,831Selective androgen receptor modulators (SARMs) and uses thereof202010,604,533Heterocycle amines and uses thereof202010,449,210Prodrug compounds and their uses201910,441,567Methods and compositions for modulating hormone levels201910,435,4295-fluorouridine monophosphate cyclic triester compounds201910,420,748Methods of treatment associated with the granulocyte colony-stimulating factor receptor201910,150,788Prodrug compounds and uses thereof201810,111,859Methods and compositions associated with the granulocyte colony-stimulating factor receptor201810,106,500Selective androgen receptor modulators (SARMs) and uses thereof201810,076,504Glucagon antagonists201810,030,034Heterocycle amines and uses thereof201810,000,522Derivatives of uridine 5'-cyclophosphate useful to treat hepatitis C viral infections20189,994,600Prodrug compounds and uses therof20189,962,370Methods of treatment associated with the granulocyte colony-stimulating factor receptor20189,676,809'Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections'20179,675,583'Selective androgen receptor modulators (SARMS) and uses thereof'20179,622,991'Hematopoietic growth factor mimetic small molecule compounds and their uses'20179,492,430'Methods and compositions associated with the granulocyte colony-stimulating factor receptor'20169,359,285'Androgen receptor modulator compounds and methods'20169,326,991'Nucleotide prodrug compounds and use'20169,266,874'Heterocycle amines and uses thereof'20169,144,557'Hematopoietic growth factor mimetic small molecule compounds and their uses'20159,139,520'Selective androgen receptor modulators (SARMs) and uses thereof'20158,865,918'Androgen receptor modulator compounds and methods'20148,796,266'Cyclothiocarbamate derivatives as progesterone receptor modulators'20148,748,633'Selective androgen receptor modulators (SARMs) and uses thereof'20148,680,150'Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors'20148,580,811'Androgen receptor modulator methods'20138,519,158'Androgen receptor modulator compounds and methods'20138,466,146'Cyclothiocarbamate derivatives as progesterone receptor modulators'20138,354,446'Selective androgen receptor modulators (SARMs) and uses thereof'20138,329,690'Cyclothiocarbamate derivatives as progesterone receptor modulators'20128,193,357'Androgen receptor modulator compounds'20127,816,372'6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds'20107,727,980'Tricyclic androgen receptor modulator compounds and methods'20107,696,246'Bicyclic androgen and progesterone receptor modulator compounds and methods'20107,691,895'Thrombopoietin activity modulating compounds and methods'20107,662,804'Thrombopoietin activity modulating compounds and methods'20107,645,761'Indoline derivatives'20107,569,564'Cyclothiocarbamate derivatives as progesterone receptor modulators'20097,488,822'Cyclocarbamate derivatives as progesterone receptor modulators'20097,442,696'Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses'20087,435,733'Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds'20087,314,887'Thrombopoietin activity modulating compounds and methods'20087,253,203'Indoline derivatives'20077,214,690'Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods'20077,163,946'5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds'20077,091,234'Thio-oxindole derivatives'20067,084,168'Indoline derivatives'20067,084,151'5-(1\',1\'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compounds'20067,081,457'Cyclothiocarbamate derivatives as progesterone receptor modulators'20067,071,205'5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds'20067,026,484'Tricyclic androgen receptor modulator compounds and methods'20066,982,261'Cyanopyrroles'20066,964,973'Bicyclic androgen and progesterone receptor modulator compounds and methods'20056,946,454'Thio-oxindole derivatives'20056,841,568'Thio-oxindole derivatives'20056,835,744'3,3-substituted indoline derivatives'20046,794,373'Contraceptive methods using benzimidazolones'20046,759,408'Combination regimens using progesterone receptor modulators'20046,713,478'Cyclocarbamate derivatives as progesterone receptor modulators'20046,696,459'Steroid receptor modulator compounds and methods'20046,693,103'1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators'20046,610,883'Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors'20036,608,068'Indoline derivatives'20036,583,145'Thio-oxindole derivatives'20036,566,358'Cyclocarbamate derivatives as progesterone receptor modulators'20036,566,372'Bicyclic androgen and progesterone receptor modulator compounds and methods'20036,562,857'Cyanopyrroles'20036,544,970'Cyclic regimens utilizing indoline derivatives'20036,521,657'Thio-oxindole derivatives'20036,509,334'Cyclocarbamate derivatives as progesterone receptor modulators'20036,503,939'Combination regimens using 3,3-substituted indoline derivatives'20036,498,154'Cyclic regimens using quinazolinone and benzoxazine derivatives'20026,462,032'Cyclic regimens utilizing indoline derivatives'20026,462,038'Androgen receptor modulator compounds and methods'20026,448,405'Steroid receptor modulator compounds and methods'20026,444,668'Combination regimens using progesterone receptor modulators'20026,441,019'Cyclocarbamate and cyclic amide derivatives'20026,436,929'Cyclothiocarbamate derivatives as progesterone receptor modulators'20026,423,699'Combination therapies using benzimidazolones'20026,417,214'3,3-substituted indoline derivatives'20026,407,101'Cyanopyrroles'20026,399,593'Cyclic regimens using cyclic urea and cyclic amide derivatives'20026,391,907'Indoline derivatives'20026,380,178'Cyclic regimens using cyclocarbamate and cyclic amide derivatives'20026,380,235'Benzimidazolones and analogues'20026,369,056'Cyclic urea and cyclic amide derivatives'20026,358,947'Tetracyclic progesterone receptor modulator compounds and methods'20026,358,948'Quinazolinone and benzoxazine derivatives as progesterone receptor modulators'20026,355,648'Thio-oxindole derivatives'20026,339,098'2,1-benzisothiazoline 2,2-dioxides'20026,329,416'Combination regimens using 3,3-substituted indoline derivatives'20016,319,912'Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides'20016,320,074'Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors'20016,306,851'Cyclocarbamate and cyclic amide derivatives'20016,121,450'Intermediates for preparation of steroid receptor modulator compounds'20006,093,821'Process for preparing steroid receptor modulator compounds'20006,005,007'Retinoids, methods for their production and use'19995,994,544'Steroid receptor modulator compounds and methods'19995,780,676'Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors'19985,696,127'Steroid receptor modulator compounds and methods'19975,696,130'Tricyclic steroid receptor modulator compounds and methods'19975,696,133'Steroid receptor modulator compounds and methods'19975,693,646'Steroid receptor modulator compounds and methods'19975,693,647'Steroid receptor modulator compounds and methods'19975,688,808'Steroid receptor modulator compounds and methods'19975,688,810'Steroid receptor modulator compounds and methods'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2020Patents assigned to LIGAND PHARM INC (96)· patent assignee history
1997–2020Based in San Diego, CA, US· patent location history
2001–2003Patents assigned to AMERICAN HOME PROD (14)· patent assignee history
2002–2010Patents assigned to WYETH CORP (26)· patent assignee history
2012–2015Patents assigned to ZHI LIN (7)· patent assignee history
2012–2015Patents assigned to SHEN YIXING (4)· patent assignee history
2013–2019Based in La Jolla, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LIGAND PHARM INC961997–2020
WYETH CORP262002–2010
AMERICAN HOME PROD142001–2003
ZHI LINself72012–2015
SHEN YIXING42012–2015
Locations
LocationPatentsSpan
San Diego, California, US1061997–2020
La Jolla, California, US52013–2019